NCT03262311View on ClinicalTrials.gov

Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 10, 2017

Primary Completion Date

September 12, 2019

Study Completion Date

September 12, 2019

Conditions
Cancer
Interventions
OTHER

Hypoxia marker

Single oral dose of pimonidazole 500 mg/m2

Trial Locations (1)

SM2 5PT

The Royal Marsden NHS Foundation Trust, Sutton

All Listed Sponsors
lead

Institute of Cancer Research, United Kingdom

OTHER

NCT03262311 - Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours | Biotech Hunter | Biotech Hunter